According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034.
All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...
According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034.
All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...
According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032.
Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...
The global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...